A randomized, double-blind, placebo- and propiverine-controlled trial of the novel antimuscarinic agent imidafenacin in Japanese patients with overactive bladder.
Autor: | Homma, Yukio1 homma-uro@umin.ac.jp, Yamaguchi, Osamu2 |
---|---|
Zdroj: | International Journal of Urology. May2009, Vol. 16 Issue 5, p499-506. 8p. 5 Charts. |
Databáze: | Academic Search Ultimate |
Externí odkaz: |